ALT FY 2009 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$319M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M-16.3% YoY

Gross Profit

$28M100.0% margin

Operating Income

-$26M-94.3% margin

Net Income

-$32M-117.2% margin

EPS (Diluted)

$-351.19

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$34M

Total Liabilities

$32M

Stockholders' Equity

$2M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$33M	-16.3%
Gross Profit	$28M	$33M	-16.3%
Operating Income	-$26M	-$35M	+26.3%
Net Income	-$32M	-$36M	+11.4%